Results 201 to 210 of about 257,826 (338)

Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives Pediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation (allo‐HSCT) are severely immunosuppressed leading to a high risk for life‐threatening infections. This trial investigates the effects of exercise during allo‐HSCT on immune cell recovery and patient‐related outcomes (DRKS00019865). Methods Twenty‐
Ronja Beller, Sabrina B. Bennstein, Dirk Reinhardt, Gabriele Gauß, Carolina Chamorra Vina, Helmut Hanenberg, Markus Uhrberg, Miriam Götte   +7 more
wiley   +1 more source

Severe gastrointestinal manifestations in childhood-onset lupus: A single-center cohort and review of the literature. [PDF]

Lupus
Orozco J, Nguyen J, Yasrebi SM, Blalock M, Grisales SL, Jensen CL, DeGuzman MM.   +6 more
europepmc   +1 more source

Cyclophosphamide in children with cancer [PDF]

Cancer, 1962
openaire   +4 more sources

Identification of Prognostic Biomarkers in Gene Expression Profile of Neuroblastoma Via Machine Learning

Pediatric Discovery, EarlyView.
This study identified 11 core prognostic biomarkers for neuroblastoma through optimized PPI networks and machine learning, revealing their correlations with chemotherapy and the tumor microenvironment, providing new insights for precision treatment and target development.
Shuxin Tang, Jinhua Fan, Yupeng Cun
wiley   +1 more source

Recovery of normal hematopoietic tissue and tumor following chemotherapeutic injury from cyclophosphamide (CTX): comparative analysis of biochemical and clinical techniques [PDF]

, 1975
SH Rosenoff, F Bostick, RC Young
openalex   +1 more source

Granulomatosis with polyangiitis induced by the anti-programmed cell death-1 inhibitor tislelizumab: A case report. [PDF]

World J Clin Cases
Zhao JH, Wang JJ, Li YW.
europepmc   +1 more source

Cyclophosphamide for clinical renal and hepatic transplantation. [PDF]

, 1973
Cascardo, S, Corman, J, Geis, P, Groth, CG, Gustafsson, A, Halgrimson, CG, Husberg, B, Iwatsuki, S, Penn, I, Putnam, CW, Starzl, TE   +10 more
core  

Reproductive adverse events in patients with non‐Hodgkin lymphoma treated with chemotherapeutic regimens including cyclophosphamide, doxorubicin, vincristine, prednisone or CHOP with rituximab: A systematic review and meta‐analysis

Pediatric Discovery, EarlyView.
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL). Nine articles involving 331 patients were included in the meta‐analysis, the pooled proportion of reproductive adverse events was 22.3% (95% CI 11.4%–33.2%; p < 0.001). The findings
Rong Han, Jie Zhao, Chengjun Yu, Ling Wang, Long Chen, Yang Hu, Shengde Wu   +6 more
wiley   +1 more source

Stimulation of granulocytic colony formation in agar diffusion chambers implanted in cyclophosphamide pretreated mice [PDF]

, 1975
M. Y. Gordon, N. M. Blackett
openalex   +1 more source

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source